描述

Metabolic pathway illustration showing how gut microbiota dysbiosis contributes to the pathogenesis of obesity and type 2 diabetes mellitus. Key microbial metabolites and their host receptor interactions are depicted.

Figure 3

Diagram

Source Paper

Gut Microbiota-Targeted Therapeutics for Metabolic Disorders: Mechanistic Insights into the Synergy of Probiotic-Fermented Herbal Bioactives.

International journal of molecular sciences (2025)

PMID: 40564947

DOI: 10.3390/ijms26125486

Cite This Figure

![Figure 3: Metabolic pathway illustration showing how gut microbiota dysbiosis contributes to the pathogenesis of obesity and type 2 diabetes mellitus. Key microbial metabolites and their host receptor interactions are depicted.]()

> Source: Yue Fan et al. "Gut Microbiota-Targeted Therapeutics for Metabolic Disorders: Mechanistic Insigh." *International journal of molecular sciences*, 2025. PMID: [40564947](https://pubmed.ncbi.nlm.nih.gov/40564947/)

<figure>
  <img src="" alt="Metabolic pathway illustration showing how gut microbiota dysbiosis contributes to the pathogenesis of obesity and type 2 diabetes mellitus. Key microbial metabolites and their host receptor interactions are depicted." />
  <figcaption>Figure 3. Metabolic pathway illustration showing how gut microbiota dysbiosis contributes to the pathogenesis of obesity and type 2 diabetes mellitus. Key microbial metabolites and their host receptor interactions are depicted.<br>  Source: Yue Fan et al. "Gut Microbiota-Targeted Therapeutics for Metabolic Disorders: Mechanistic Insigh." <em>International journal of molecular sciences</em>, 2025. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40564947/">40564947</a></figcaption>
</figure>

描述

Figure 3

Source Paper

Cite This Figure

相关证据